Vanguard Investments Australia’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
Vanguard Investments Australia's ASTH Position: Q2 2026 in Review
Vanguard Investments Australia reduced its Astrana Health (ASTH) stake by 8.5% in Q2 2026, selling an estimated $38.5K and leaving 11,528 shares worth $535K. The position accounts for ﹤0.01% of the portfolio, ranked #1626.
Vanguard Investments Australia first reported a position in ASTH in Q1 2026 and has held it in 2 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Vanguard Investments Australia held 11,528 shares of Astrana Health worth $535K as of Q2 2026.
- Vanguard Investments Australia sold 1,070 Astrana Health shares in Q2 2026, an estimated $38.5K.
- Astrana Health made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1626 holding.
- Vanguard Investments Australia first reported a position in Astrana Health in Q1 2026 and has held it in 2 quarters since.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.